Skip to records

Therapeutics

229Aging Biotech
100 of 229 records

PP405

Source date not recordedAnalyse record ↗

Investigational topical MPC inhibitor designed to reactivate dormant hair-follicle stem cells by changing their metabolic state.

Modality
topical small-molecule mitochondrial pyruvate carrier inhibitor
Availability (US)
Phase 2; completed Phase 2a and registered later-stage study not yet recruiting as of 2026-09-28
Biomarkers
hair-follicle Ki-67; lactate dehydrogenase activity; local tolerability; pharmacokinetics; hair density
Hallmark targeted
stem-cell exhaustion, mitochondrial metabolism, loss of regenerative capacity
Kind
investigational drug
Clinical trials
NCT06393452 completed Phase 2a; NCT07819435 Phase 2/3 registered and not yet recruiting